Replay available

Avita Medical, Inc. (RCEL) Q4 2025 Earnings Call

Avita Medical, Inc. (NASDAQ: RCEL) Q4 2025 earnings conference call, held 2026-02-12. Replay captured from the company's public earnings webcast.

Thu, February 12, 2026 at 4:30 PMendedReplay
Avita Medical, Inc. (RCEL) Q4 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Ben Atkins

Host

Kerry Vance

Interim Chief Executive Officer

David O'Toole

Chief Financial Officer

Ryan Zimmerman

Analyst at BTIG

Josh Jennings

Analyst at TD Cal

Ian Arndt

Analyst at Lake Street Capital Markets

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the Aveda Medical Inc. Fourth Quarter and Full Year 2025 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1-1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1-1 again. Please revise that today's conference is pre-recorded. on our conference. Over to your first speaker today, Ben Atkins, please go ahead. Thank you, Operator. Welcome to Avita Medical's fourth quarter and full year 2025 earnings call. Joining me on today's call are Carrie Vance, Interim Chief Executive Officer, and David O'Toole, Chief Financial Officer. Today's earnings release and presentation are available on our website at www.avitamedical.com under the investor relations section. Before we begin, I would like to remind you that this call includes forward-looking statements within the meaning of the private securities litigation reform act of 1995. These statements are neither promises nor guarantees and involve known and unknown risks and uncertainties that could cause actual results to differ materially from any expectations expressed or implied by the forward-looking statements. Please review our most recent filings with the SEC for comprehensive descriptions of the risk factors. Any forward-looking statements provided during this call are based on management's expectations as of today. I will now send the call over to Kerry. Good afternoon in the US and good morning in Australia. Thank you for joining us today. Before we get into the numbers, I want to start by coming back to how we cl...

More from Avita Medical, Inc.